| 0 |
CHEMICAL BURN OF GENITALIA |
78 |
0.6393 |
| 1 |
VULVOVAGINAL BURNING SENSATION |
1919 |
0.3141 |
| 2 |
VULVOVAGINAL EXFOLIATION |
12 |
0.2308 |
| 3 |
VAGINAL EROSION |
35 |
0.2244 |
| 4 |
VULVOVAGINAL PAIN |
1055 |
0.2188 |
| 5 |
INFECTIVE CORNEAL ULCER |
6 |
0.2143 |
| 6 |
VULVOVAGINAL SWELLING |
325 |
0.1778 |
| 7 |
VAGINAL MUCOSAL BLISTERING |
36 |
0.1600 |
| 8 |
VULVOVAGINAL INJURY |
80 |
0.1404 |
| 9 |
VULVOVAGINAL ERYTHEMA |
115 |
0.1376 |
| 10 |
VULVOVAGINAL PRURITUS |
630 |
0.1243 |
| 11 |
INFECTIVE KERATITIS |
8 |
0.1127 |
| 12 |
VULVOVAGINAL DISCOMFORT |
480 |
0.1085 |
| 13 |
ENCEPHALITIC INFECTION |
4 |
0.1081 |
| 14 |
VULVOVAGINAL INFLAMMATION |
45 |
0.0976 |
| 15 |
VAGINAL EXFOLIATION |
5 |
0.0962 |
| 16 |
TONGUE NECROSIS |
7 |
0.0959 |
| 17 |
VULVOVAGINAL RASH |
31 |
0.0703 |
| 18 |
ENCEPHALITIS FUNGAL |
6 |
0.0667 |
| 19 |
VAGINAL LACERATION |
13 |
0.0596 |
| 20 |
CHOLESTASIS OF PREGNANCY |
26 |
0.0565 |
| 21 |
PRODUCT USED FOR UNKNOWN INDICATION |
66 |
0.0524 |
| 22 |
PHARYNGEAL HAEMATOMA |
6 |
0.0496 |
| 23 |
VAGINAL SWELLING |
17 |
0.0478 |
| 24 |
CHEMICAL BURN |
55 |
0.0477 |
| 25 |
GENITAL BLISTER |
12 |
0.0433 |
| 26 |
TONGUE HAEMATOMA |
7 |
0.0354 |
| 27 |
GENITAL PARAESTHESIA |
10 |
0.0345 |
| 28 |
GENITAL BURNING SENSATION |
19 |
0.0219 |
| 29 |
OEDEMA GENITAL |
13 |
0.0203 |
| 30 |
VAGINAL LESION |
6 |
0.0196 |
| 31 |
CHEMICAL INJURY |
16 |
0.0196 |
| 32 |
KERATITIS FUNGAL |
4 |
0.0192 |
| 33 |
VAGINAL ULCERATION |
8 |
0.0190 |
| 34 |
VULVAL DISORDER |
12 |
0.0182 |
| 35 |
GENITAL SWELLING |
11 |
0.0159 |
| 36 |
CONGENITAL HYPOTHYROIDISM |
4 |
0.0155 |
| 37 |
VAGINAL BURNING SENSATION |
7 |
0.0149 |
| 38 |
PRODUCT IMPURITY |
4 |
0.0146 |
| 39 |
VAGINAL DISCHARGE |
140 |
0.0138 |
| 40 |
PRIMARY ADRENAL INSUFFICIENCY |
4 |
0.0131 |
| 41 |
GENITAL PRURITUS FEMALE |
4 |
0.0123 |
| 42 |
PERIPHERAL NERVE LESION |
4 |
0.0121 |
| 43 |
VAGINAL HAEMORRHAGE |
494 |
0.0114 |
| 44 |
CORYNEBACTERIUM INFECTION |
6 |
0.0112 |
| 45 |
TOXIC SHOCK SYNDROME |
7 |
0.0111 |
| 46 |
OESOPHAGEAL MOTILITY DISORDER |
4 |
0.0111 |
| 47 |
MESOTHELIOMA MALIGNANT |
4 |
0.0108 |
| 48 |
VAGINAL DISORDER |
10 |
0.0104 |
| 49 |
CHEMICAL BURN OF SKIN |
26 |
0.0102 |
| 50 |
GENITAL ERYTHEMA |
5 |
0.0101 |
| 51 |
INDUCED LABOUR |
6 |
0.0101 |
| 52 |
GENITAL RASH |
14 |
0.0098 |
| 53 |
SKIN CANDIDA |
5 |
0.0096 |
| 54 |
VAGINAL ODOUR |
11 |
0.0087 |
| 55 |
PERINEAL PAIN |
6 |
0.0084 |
| 56 |
ALLERGIC COUGH |
6 |
0.0078 |
| 57 |
PAROTID GLAND ENLARGEMENT |
5 |
0.0077 |
| 58 |
CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE |
5 |
0.0076 |
| 59 |
VULVOVAGINAL CANDIDIASIS |
10 |
0.0074 |
| 60 |
FUNGAL SEPSIS |
6 |
0.0072 |
| 61 |
APPLICATION SITE WARMTH |
9 |
0.0071 |
| 62 |
JARISCH-HERXHEIMER REACTION |
5 |
0.0070 |
| 63 |
HAEMATOMA INFECTION |
4 |
0.0069 |
| 64 |
NEURAL TUBE DEFECT |
5 |
0.0069 |
| 65 |
CLEFT LIP |
6 |
0.0069 |
| 66 |
GENITAL HYPOAESTHESIA |
7 |
0.0069 |
| 67 |
GENITAL PAIN |
10 |
0.0068 |
| 68 |
VULVOVAGINAL MYCOTIC INFECTION |
25 |
0.0063 |
| 69 |
INTERNATIONAL NORMALISED RATIO INCREASED |
178 |
0.0062 |
| 70 |
HERPES ZOSTER DISSEMINATED |
5 |
0.0062 |
| 71 |
APPLICATION SITE PAIN |
137 |
0.0062 |
| 72 |
VULVOVAGINAL DRYNESS |
20 |
0.0062 |
| 73 |
MESOTHELIOMA |
8 |
0.0062 |
| 74 |
GINGIVAL DISCOMFORT |
4 |
0.0061 |
| 75 |
DEAFNESS TRANSITORY |
5 |
0.0059 |
| 76 |
GRAVITATIONAL OEDEMA |
4 |
0.0058 |
| 77 |
HYDRONEPHROSIS |
43 |
0.0057 |
| 78 |
HAEMORRHAGE SUBCUTANEOUS |
20 |
0.0056 |
| 79 |
BLOODY DISCHARGE |
6 |
0.0052 |
| 80 |
COAGULATION TEST ABNORMAL |
4 |
0.0052 |
| 81 |
ANAPHYLACTOID REACTION |
21 |
0.0051 |
| 82 |
CYTOMEGALOVIRUS TEST POSITIVE |
9 |
0.0050 |
| 83 |
APPLICATION SITE BURN |
24 |
0.0049 |
| 84 |
PREMATURE LABOUR |
27 |
0.0048 |
| 85 |
APPLICATION SITE SWELLING |
23 |
0.0046 |
| 86 |
TINEA INFECTION |
5 |
0.0045 |
| 87 |
ANOGENITAL WARTS |
4 |
0.0045 |
| 88 |
BACTERIAL VAGINOSIS |
7 |
0.0045 |
| 89 |
CRYPTORCHISM |
5 |
0.0045 |
| 90 |
TINEA PEDIS |
7 |
0.0044 |
| 91 |
ADMINISTRATION SITE PAIN |
5 |
0.0043 |
| 92 |
CHRONIC RESPIRATORY FAILURE |
5 |
0.0041 |
| 93 |
BETA HAEMOLYTIC STREPTOCOCCAL INFECTION |
5 |
0.0040 |
| 94 |
APPLICATION SITE DISCOMFORT |
7 |
0.0039 |
| 95 |
PNEUMOMEDIASTINUM |
7 |
0.0039 |
| 96 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
4 |
0.0038 |
| 97 |
SKIN EROSION |
11 |
0.0034 |
| 98 |
VAGINAL INFECTION |
16 |
0.0034 |
| 99 |
ONYCHOMADESIS |
14 |
0.0033 |
| 100 |
APPLICATION SITE HAEMORRHAGE |
9 |
0.0033 |
| 101 |
NEPHROGENIC ANAEMIA |
15 |
0.0032 |
| 102 |
STOMA SITE ERYTHEMA |
6 |
0.0032 |
| 103 |
IMMUNE RECONSTITUTION SYNDROME |
4 |
0.0031 |
| 104 |
ASPERGILLOSIS |
4 |
0.0031 |
| 105 |
CARDIOACTIVE DRUG LEVEL INCREASED |
4 |
0.0030 |
| 106 |
ORAL CANDIDIASIS |
39 |
0.0030 |
| 107 |
TONGUE BITING |
6 |
0.0029 |
| 108 |
LIVE BIRTH |
24 |
0.0029 |
| 109 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
48 |
0.0028 |
| 110 |
OEDEMA MOUTH |
9 |
0.0028 |
| 111 |
MATERNAL DRUGS AFFECTING FOETUS |
21 |
0.0027 |
| 112 |
CANCER PAIN |
7 |
0.0027 |
| 113 |
DYSURIA |
96 |
0.0026 |
| 114 |
CUTANEOUS LUPUS ERYTHEMATOSUS |
5 |
0.0026 |
| 115 |
APPLICATION SITE PRURITUS |
58 |
0.0026 |
| 116 |
APLASIA |
5 |
0.0026 |
| 117 |
PRURITUS GENITAL |
6 |
0.0025 |
| 118 |
HEART DISEASE CONGENITAL |
9 |
0.0025 |
| 119 |
FUNGAEMIA |
4 |
0.0025 |
| 120 |
BURNING SENSATION |
175 |
0.0025 |
| 121 |
CANDIDIASIS |
10 |
0.0025 |
| 122 |
FUNGAL SKIN INFECTION |
10 |
0.0025 |
| 123 |
ANAL PRURITUS |
5 |
0.0024 |
| 124 |
HYPERPARATHYROIDISM SECONDARY |
6 |
0.0024 |
| 125 |
ANORECTAL DISCOMFORT |
12 |
0.0023 |
| 126 |
DRUG MONITORING PROCEDURE NOT PERFORMED |
4 |
0.0022 |
| 127 |
HYPERNATRAEMIA |
11 |
0.0022 |
| 128 |
STOMA SITE DISCHARGE |
6 |
0.0022 |
| 129 |
LOBAR PNEUMONIA |
4 |
0.0022 |
| 130 |
JAUNDICE NEONATAL |
4 |
0.0021 |
| 131 |
LACUNAR INFARCTION |
5 |
0.0021 |
| 132 |
NASAL DRYNESS |
13 |
0.0021 |
| 133 |
TONGUE ULCERATION |
7 |
0.0021 |
| 134 |
PNEUMONIA FUNGAL |
8 |
0.0020 |
| 135 |
RETROPERITONEAL HAEMORRHAGE |
5 |
0.0020 |
| 136 |
SUFFOCATION FEELING |
5 |
0.0020 |
| 137 |
FUNGAL INFECTION |
67 |
0.0020 |
| 138 |
THERMAL BURN |
14 |
0.0020 |
| 139 |
EXPIRED PRODUCT ADMINISTERED |
65 |
0.0020 |
| 140 |
VENTRICULAR SEPTAL DEFECT |
11 |
0.0019 |
| 141 |
ATRIAL SEPTAL DEFECT |
16 |
0.0019 |
| 142 |
CONDITION AGGRAVATED |
580 |
0.0019 |
| 143 |
SKIN ABRASION |
9 |
0.0019 |
| 144 |
DRUG INTERACTION |
302 |
0.0019 |
| 145 |
CONJUNCTIVAL HAEMORRHAGE |
7 |
0.0018 |
| 146 |
MACULE |
5 |
0.0018 |
| 147 |
ERYSIPELAS |
9 |
0.0018 |
| 148 |
PRODUCT SOLUBILITY ABNORMAL |
9 |
0.0018 |
| 149 |
CANDIDA INFECTION |
30 |
0.0018 |
| 150 |
COMPUTERISED TOMOGRAM ABNORMAL |
4 |
0.0018 |
| 151 |
BLOOD LOSS ANAEMIA |
4 |
0.0018 |
| 152 |
OESOPHAGEAL CANDIDIASIS |
7 |
0.0018 |
| 153 |
HAEMATURIA |
59 |
0.0017 |
| 154 |
INGROWING NAIL |
4 |
0.0017 |
| 155 |
HAEMORRHAGIC DIATHESIS |
6 |
0.0017 |
| 156 |
CYTOMEGALOVIRUS INFECTION |
28 |
0.0017 |
| 157 |
GESTATIONAL DIABETES |
8 |
0.0017 |
| 158 |
GRAFT VERSUS HOST DISEASE |
12 |
0.0017 |
| 159 |
HUMERUS FRACTURE |
8 |
0.0017 |
| 160 |
STILLBIRTH |
8 |
0.0017 |
| 161 |
REBOUND ACID HYPERSECRETION |
5 |
0.0017 |
| 162 |
BREATH ODOUR |
4 |
0.0016 |
| 163 |
EXPIRED DRUG ADMINISTERED |
8 |
0.0016 |
| 164 |
HYPERACUSIS |
6 |
0.0016 |
| 165 |
ECCHYMOSIS |
11 |
0.0016 |
| 166 |
DECUBITUS ULCER |
13 |
0.0016 |
| 167 |
EXCORIATION |
4 |
0.0016 |
| 168 |
SCREAMING |
10 |
0.0016 |
| 169 |
STUPOR |
5 |
0.0016 |
| 170 |
FAILURE TO THRIVE |
8 |
0.0015 |
| 171 |
URINE ODOUR ABNORMAL |
9 |
0.0015 |
| 172 |
ODYNOPHAGIA |
9 |
0.0015 |
| 173 |
HAEMATOMA |
39 |
0.0015 |
| 174 |
PROTHROMBIN TIME PROLONGED |
9 |
0.0015 |
| 175 |
DERMATITIS ACNEIFORM |
9 |
0.0015 |
| 176 |
EYE MOVEMENT DISORDER |
10 |
0.0015 |
| 177 |
PRODUCT USE COMPLAINT |
23 |
0.0015 |
| 178 |
REGURGITATION |
5 |
0.0015 |
| 179 |
APPLICATION SITE IRRITATION |
18 |
0.0014 |
| 180 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
15 |
0.0014 |
| 181 |
APPLICATION SITE REACTION |
10 |
0.0014 |
| 182 |
NECROTISING FASCIITIS |
5 |
0.0014 |
| 183 |
CLOSTRIDIUM DIFFICILE COLITIS |
15 |
0.0014 |
| 184 |
GLOSSITIS |
5 |
0.0014 |
| 185 |
ABSCESS LIMB |
6 |
0.0014 |
| 186 |
OESOPHAGEAL STENOSIS |
4 |
0.0014 |
| 187 |
PULMONARY HAEMORRHAGE |
11 |
0.0014 |
| 188 |
CONJUNCTIVAL HYPERAEMIA |
5 |
0.0014 |
| 189 |
SKIN WEEPING |
5 |
0.0014 |
| 190 |
RASH PUSTULAR |
10 |
0.0014 |
| 191 |
MOUTH HAEMORRHAGE |
10 |
0.0014 |
| 192 |
STEVENS-JOHNSON SYNDROME |
30 |
0.0013 |
| 193 |
MENINGITIS |
9 |
0.0013 |
| 194 |
PARTIAL SEIZURES |
7 |
0.0013 |
| 195 |
METABOLIC ENCEPHALOPATHY |
4 |
0.0013 |
| 196 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
5 |
0.0013 |
| 197 |
HYPERCAPNIA |
4 |
0.0013 |
| 198 |
URINE ABNORMALITY |
6 |
0.0013 |
| 199 |
MICTURITION URGENCY |
15 |
0.0013 |
| 200 |
MEDICAL DEVICE DISCOMFORT |
4 |
0.0013 |
| 201 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
5 |
0.0013 |
| 202 |
UNDERDOSE |
95 |
0.0013 |
| 203 |
ACUTE RESPIRATORY FAILURE |
25 |
0.0013 |
| 204 |
DIASTOLIC DYSFUNCTION |
4 |
0.0013 |
| 205 |
PATENT DUCTUS ARTERIOSUS |
5 |
0.0013 |
| 206 |
PNEUMONIA VIRAL |
4 |
0.0013 |
| 207 |
SPINAL OSTEOARTHRITIS |
11 |
0.0013 |
| 208 |
EXPOSURE TO TOXIC AGENT |
4 |
0.0012 |
| 209 |
CUSHINGOID |
4 |
0.0012 |
| 210 |
BLOOD CALCIUM DECREASED |
14 |
0.0012 |
| 211 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
5 |
0.0012 |
| 212 |
FACIAL PAIN |
11 |
0.0012 |
| 213 |
APPLICATION SITE DISCOLOURATION |
5 |
0.0012 |
| 214 |
FULL BLOOD COUNT ABNORMAL |
13 |
0.0012 |
| 215 |
BACTERIAL SEPSIS |
4 |
0.0012 |
| 216 |
MOUTH SWELLING |
7 |
0.0012 |
| 217 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
4 |
0.0012 |
| 218 |
END STAGE RENAL DISEASE |
22 |
0.0012 |
| 219 |
RALES |
7 |
0.0012 |
| 220 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
43 |
0.0012 |
| 221 |
EOSINOPHILIA |
21 |
0.0012 |
| 222 |
PROSTATE CANCER METASTATIC |
4 |
0.0012 |
| 223 |
UROSEPSIS |
11 |
0.0012 |
| 224 |
INTERVERTEBRAL DISC DEGENERATION |
11 |
0.0012 |
| 225 |
ECONOMIC PROBLEM |
18 |
0.0012 |
| 226 |
TOOTH ABSCESS |
12 |
0.0012 |
| 227 |
DRUG EXPOSURE DURING PREGNANCY |
40 |
0.0012 |
| 228 |
PERICARDIAL EFFUSION |
27 |
0.0012 |
| 229 |
CARDIAC MURMUR |
10 |
0.0012 |
| 230 |
ORAL DISCOMFORT |
16 |
0.0012 |
| 231 |
ABDOMINAL PAIN LOWER |
29 |
0.0011 |
| 232 |
DERMATITIS CONTACT |
13 |
0.0011 |
| 233 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
10 |
0.0011 |
| 234 |
RESPIRATORY RATE INCREASED |
10 |
0.0011 |
| 235 |
TOXIC EPIDERMAL NECROLYSIS |
17 |
0.0011 |
| 236 |
MONOCYTE COUNT INCREASED |
4 |
0.0011 |
| 237 |
SALIVARY HYPERSECRETION |
11 |
0.0011 |
| 238 |
FAECALOMA |
6 |
0.0011 |
| 239 |
SENSITIVE SKIN |
8 |
0.0011 |
| 240 |
APPLICATION SITE VESICLES |
7 |
0.0011 |
| 241 |
SPINAL COLUMN STENOSIS |
5 |
0.0011 |
| 242 |
FACE INJURY |
4 |
0.0011 |
| 243 |
MOUTH ULCERATION |
22 |
0.0010 |
| 244 |
PRODUCT ADMINISTRATION ERROR |
21 |
0.0010 |
| 245 |
AGRANULOCYTOSIS |
19 |
0.0010 |
| 246 |
HYPOKALAEMIA |
47 |
0.0010 |
| 247 |
CELLULITIS |
51 |
0.0010 |
| 248 |
BLOOD CREATININE INCREASED |
66 |
0.0010 |
| 249 |
TRICUSPID VALVE INCOMPETENCE |
8 |
0.0010 |
| 250 |
HYPERLIPIDAEMIA |
12 |
0.0010 |
| 251 |
DERMATITIS |
21 |
0.0010 |
| 252 |
GANGRENE |
6 |
0.0010 |
| 253 |
SCAR |
17 |
0.0010 |
| 254 |
PRODUCT PHYSICAL ISSUE |
20 |
0.0010 |
| 255 |
LIP DRY |
9 |
0.0010 |
| 256 |
ADRENAL INSUFFICIENCY |
12 |
0.0010 |
| 257 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
5 |
0.0010 |
| 258 |
ADVERSE REACTION |
13 |
0.0010 |
| 259 |
PERIPHERAL VENOUS DISEASE |
4 |
0.0010 |
| 260 |
ORTHOSTATIC HYPOTENSION |
17 |
0.0010 |
| 261 |
HYPERSENSITIVITY |
181 |
0.0010 |
| 262 |
CEREBRAL ISCHAEMIA |
5 |
0.0010 |
| 263 |
CONJUNCTIVITIS |
18 |
0.0010 |
| 264 |
SEPSIS |
108 |
0.0010 |
| 265 |
BENIGN PROSTATIC HYPERPLASIA |
5 |
0.0010 |
| 266 |
TONGUE DISORDER |
7 |
0.0010 |
| 267 |
PREMATURE BABY |
29 |
0.0010 |
| 268 |
BASAL CELL CARCINOMA |
15 |
0.0010 |
| 269 |
ACCIDENTAL EXPOSURE |
4 |
0.0010 |
| 270 |
BLOOD URINE PRESENT |
18 |
0.0009 |
| 271 |
HYPOPHOSPHATAEMIA |
7 |
0.0009 |
| 272 |
DRUG INEFFECTIVE |
1241 |
0.0009 |
| 273 |
ENTERITIS |
6 |
0.0009 |
| 274 |
CHRONIC KIDNEY DISEASE |
71 |
0.0009 |
| 275 |
PROCTALGIA |
6 |
0.0009 |
| 276 |
HEREDITARY ANGIOEDEMA |
10 |
0.0009 |
| 277 |
BREAST CANCER METASTATIC |
10 |
0.0009 |
| 278 |
CHROMATURIA |
21 |
0.0009 |
| 279 |
ANAL ABSCESS |
5 |
0.0009 |
| 280 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
20 |
0.0009 |
| 281 |
SKIN SWELLING |
8 |
0.0009 |
| 282 |
PHARYNGEAL SWELLING |
9 |
0.0009 |
| 283 |
BLOOD CALCIUM INCREASED |
8 |
0.0009 |
| 284 |
ONYCHOMYCOSIS |
4 |
0.0009 |
| 285 |
RENAL FAILURE CHRONIC |
7 |
0.0009 |
| 286 |
STAPHYLOCOCCAL INFECTION |
30 |
0.0009 |
| 287 |
PRODUCT FORMULATION ISSUE |
6 |
0.0009 |
| 288 |
HAEMATEMESIS |
23 |
0.0009 |
| 289 |
SLEEP DISORDER |
64 |
0.0009 |
| 290 |
HYPERKERATOSIS |
5 |
0.0009 |
| 291 |
HYPONATRAEMIA |
51 |
0.0009 |
| 292 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
5 |
0.0009 |
| 293 |
HYPOTONIA |
9 |
0.0009 |
| 294 |
CARDIOMEGALY |
11 |
0.0009 |
| 295 |
FLUID OVERLOAD |
13 |
0.0009 |
| 296 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
15 |
0.0009 |
| 297 |
SKIN INFECTION |
10 |
0.0009 |
| 298 |
POSTOPERATIVE WOUND INFECTION |
6 |
0.0009 |
| 299 |
EXPOSURE DURING PREGNANCY |
55 |
0.0009 |
| 300 |
DRUG EFFECT LESS THAN EXPECTED |
13 |
0.0009 |
| 301 |
ANHEDONIA |
23 |
0.0009 |
| 302 |
HAEMORRHAGE INTRACRANIAL |
13 |
0.0009 |
| 303 |
MULTI-ORGAN FAILURE |
15 |
0.0009 |
| 304 |
HEPATIC CYTOLYSIS |
11 |
0.0009 |
| 305 |
PETECHIAE |
9 |
0.0009 |
| 306 |
URINARY TRACT INFECTION |
147 |
0.0009 |
| 307 |
PAPULE |
6 |
0.0009 |
| 308 |
ABASIA |
21 |
0.0008 |
| 309 |
DIVERTICULUM |
6 |
0.0008 |
| 310 |
EMBOLISM |
7 |
0.0008 |
| 311 |
RECALLED PRODUCT ADMINISTERED |
8 |
0.0008 |
| 312 |
ATELECTASIS |
8 |
0.0008 |
| 313 |
FOETAL GROWTH RESTRICTION |
5 |
0.0008 |
| 314 |
VITAMIN D DEFICIENCY |
8 |
0.0008 |
| 315 |
OBESITY |
13 |
0.0008 |
| 316 |
SWELLING FACE |
53 |
0.0008 |
| 317 |
BLINDNESS TRANSIENT |
6 |
0.0008 |
| 318 |
BREATH SOUNDS ABNORMAL |
4 |
0.0008 |
| 319 |
LIP SWELLING |
27 |
0.0008 |
| 320 |
ABDOMINAL TENDERNESS |
4 |
0.0008 |
| 321 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
20 |
0.0008 |
| 322 |
MALNUTRITION |
9 |
0.0008 |
| 323 |
PROTEIN URINE PRESENT |
4 |
0.0008 |
| 324 |
DERMATITIS EXFOLIATIVE |
4 |
0.0008 |
| 325 |
POLLAKIURIA |
33 |
0.0008 |
| 326 |
MYOCARDIAL ISCHAEMIA |
9 |
0.0008 |
| 327 |
SLEEP APNOEA SYNDROME |
15 |
0.0008 |
| 328 |
WRONG DRUG ADMINISTERED |
7 |
0.0008 |
| 329 |
DRUG LEVEL INCREASED |
13 |
0.0008 |
| 330 |
ABDOMINAL PAIN |
182 |
0.0008 |
| 331 |
INCORRECT DRUG ADMINISTRATION DURATION |
22 |
0.0008 |
| 332 |
RENAL FAILURE ACUTE |
33 |
0.0008 |
| 333 |
PERIPHERAL VASCULAR DISORDER |
4 |
0.0008 |
| 334 |
BRONCHOPULMONARY ASPERGILLOSIS |
6 |
0.0008 |
| 335 |
ENCEPHALOPATHY |
19 |
0.0008 |
| 336 |
APNOEA |
6 |
0.0008 |
| 337 |
HERPES SIMPLEX |
5 |
0.0008 |
| 338 |
RECTAL HAEMORRHAGE |
33 |
0.0008 |
| 339 |
APLASTIC ANAEMIA |
4 |
0.0008 |
| 340 |
PNEUMONIA BACTERIAL |
7 |
0.0008 |
| 341 |
BACTERAEMIA |
9 |
0.0008 |
| 342 |
IRON DEFICIENCY ANAEMIA |
7 |
0.0008 |
| 343 |
LIVER FUNCTION TEST ABNORMAL |
22 |
0.0008 |
| 344 |
BLOOD ALBUMIN DECREASED |
6 |
0.0008 |
| 345 |
MENTAL STATUS CHANGES |
21 |
0.0008 |
| 346 |
ATRIAL FLUTTER |
6 |
0.0008 |
| 347 |
BLOOD DISORDER |
6 |
0.0007 |
| 348 |
OBSESSIVE-COMPULSIVE DISORDER |
6 |
0.0007 |
| 349 |
FLANK PAIN |
7 |
0.0007 |
| 350 |
CHEILITIS |
4 |
0.0007 |
| 351 |
NO THERAPEUTIC RESPONSE |
9 |
0.0007 |
| 352 |
PRODUCT LABEL ISSUE |
5 |
0.0007 |
| 353 |
PRODUCT PACKAGING ISSUE |
7 |
0.0007 |
| 354 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
5 |
0.0007 |
| 355 |
PANCYTOPENIA |
41 |
0.0007 |
| 356 |
GLOMERULAR FILTRATION RATE DECREASED |
9 |
0.0007 |
| 357 |
ESCHERICHIA INFECTION |
6 |
0.0007 |
| 358 |
LYMPHOEDEMA |
5 |
0.0007 |
| 359 |
GASTRIC ULCER HAEMORRHAGE |
4 |
0.0007 |
| 360 |
ON AND OFF PHENOMENON |
4 |
0.0007 |
| 361 |
NERVE INJURY |
8 |
0.0007 |
| 362 |
LEUKOCYTOSIS |
13 |
0.0007 |
| 363 |
SKIN FISSURES |
14 |
0.0007 |
| 364 |
PHARYNGEAL OEDEMA |
11 |
0.0007 |
| 365 |
DEVICE RELATED INFECTION |
11 |
0.0007 |
| 366 |
PERICARDITIS |
12 |
0.0007 |
| 367 |
ANGIOPATHY |
4 |
0.0007 |
| 368 |
URINARY INCONTINENCE |
21 |
0.0007 |
| 369 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
14 |
0.0007 |
| 370 |
MITRAL VALVE INCOMPETENCE |
8 |
0.0007 |
| 371 |
HYPERTONIA |
4 |
0.0007 |
| 372 |
SKIN ULCER |
18 |
0.0007 |
| 373 |
BLOOD MAGNESIUM DECREASED |
6 |
0.0007 |
| 374 |
BLISTER |
39 |
0.0007 |
| 375 |
HERPES VIRUS INFECTION |
4 |
0.0007 |
| 376 |
CYSTITIS |
22 |
0.0007 |
| 377 |
HYPERVENTILATION |
4 |
0.0007 |
| 378 |
CRYING |
25 |
0.0007 |
| 379 |
MAJOR DEPRESSION |
5 |
0.0007 |
| 380 |
HYPOVOLAEMIA |
4 |
0.0007 |
| 381 |
TOOTH INFECTION |
9 |
0.0007 |
| 382 |
MELAENA |
15 |
0.0007 |
| 383 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
12 |
0.0007 |
| 384 |
BLOOD POTASSIUM INCREASED |
11 |
0.0007 |
| 385 |
SKIN IRRITATION |
31 |
0.0007 |
| 386 |
SKIN HAEMORRHAGE |
10 |
0.0007 |
| 387 |
ACUTE KIDNEY INJURY |
103 |
0.0007 |
| 388 |
DISCOMFORT |
41 |
0.0007 |
| 389 |
SCRATCH |
7 |
0.0007 |
| 390 |
PELVIC PAIN |
12 |
0.0007 |
| 391 |
COAGULOPATHY |
11 |
0.0007 |
| 392 |
TROPONIN INCREASED |
5 |
0.0007 |
| 393 |
HAEMATOCRIT DECREASED |
13 |
0.0007 |
| 394 |
INCREASED TENDENCY TO BRUISE |
6 |
0.0007 |
| 395 |
FOOD ALLERGY |
5 |
0.0006 |
| 396 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
4 |
0.0006 |
| 397 |
CONGENITAL ANOMALY |
5 |
0.0006 |
| 398 |
PELVIC FRACTURE |
5 |
0.0006 |
| 399 |
ACUTE MYELOID LEUKAEMIA |
10 |
0.0006 |
| 400 |
SWELLING |
60 |
0.0006 |
| 401 |
OESOPHAGITIS |
7 |
0.0006 |
| 402 |
BONE MARROW FAILURE |
13 |
0.0006 |
| 403 |
ARTERIOSCLEROSIS |
6 |
0.0006 |
| 404 |
OSTEOARTHRITIS |
27 |
0.0006 |
| 405 |
MULTIPLE INJURIES |
4 |
0.0006 |
| 406 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
14 |
0.0006 |
| 407 |
TOOTH LOSS |
13 |
0.0006 |
| 408 |
HYPOXIA |
22 |
0.0006 |
| 409 |
PULMONARY HYPERTENSION |
13 |
0.0006 |
| 410 |
HYPERCHOLESTEROLAEMIA |
6 |
0.0006 |
| 411 |
SKIN EXFOLIATION |
52 |
0.0006 |
| 412 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
18 |
0.0006 |
| 413 |
RENAL TUBULAR NECROSIS |
6 |
0.0006 |
| 414 |
HEPATOMEGALY |
6 |
0.0006 |
| 415 |
RASH PRURITIC |
33 |
0.0006 |
| 416 |
MULTIPLE FRACTURES |
10 |
0.0006 |
| 417 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
43 |
0.0006 |
| 418 |
CARDIAC FAILURE ACUTE |
4 |
0.0006 |
| 419 |
PNEUMONIA ASPIRATION |
15 |
0.0006 |
| 420 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
11 |
0.0006 |
| 421 |
ATRIOVENTRICULAR BLOCK COMPLETE |
4 |
0.0006 |
| 422 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
6 |
0.0006 |
| 423 |
CHOLECYSTITIS CHRONIC |
4 |
0.0006 |
| 424 |
BLOOD UREA INCREASED |
10 |
0.0006 |
| 425 |
POST-TRAUMATIC STRESS DISORDER |
4 |
0.0006 |
| 426 |
UNEVALUABLE EVENT |
45 |
0.0006 |
| 427 |
OSTEOPENIA |
9 |
0.0006 |
| 428 |
CONTUSION |
57 |
0.0006 |
| 429 |
UTERINE PERFORATION |
5 |
0.0006 |
| 430 |
ALANINE AMINOTRANSFERASE INCREASED |
36 |
0.0006 |
| 431 |
GASTROINTESTINAL HAEMORRHAGE |
49 |
0.0006 |
| 432 |
RASH ERYTHEMATOUS |
28 |
0.0006 |
| 433 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
4 |
0.0006 |
| 434 |
BLOOD SODIUM DECREASED |
11 |
0.0006 |
| 435 |
PSEUDOMONAS INFECTION |
5 |
0.0006 |
| 436 |
THROMBOCYTOPENIA |
65 |
0.0006 |
| 437 |
HYPOCALCAEMIA |
11 |
0.0006 |
| 438 |
VENTRICULAR EXTRASYSTOLES |
6 |
0.0006 |
| 439 |
PYELONEPHRITIS |
5 |
0.0006 |
| 440 |
PLEURAL EFFUSION |
35 |
0.0006 |
| 441 |
INTENTIONAL DRUG MISUSE |
12 |
0.0006 |
| 442 |
CHOLESTASIS |
11 |
0.0006 |
| 443 |
DEMENTIA |
16 |
0.0006 |
| 444 |
CYANOSIS |
9 |
0.0006 |
| 445 |
CYTOPENIA |
7 |
0.0006 |
| 446 |
CARPAL TUNNEL SYNDROME |
8 |
0.0006 |
| 447 |
SKIN DISORDER |
19 |
0.0006 |
| 448 |
NEUROPATHY PERIPHERAL |
54 |
0.0006 |
| 449 |
PAIN IN JAW |
16 |
0.0006 |
| 450 |
HAEMORRHOIDS |
11 |
0.0006 |
| 451 |
MUSCULAR WEAKNESS |
64 |
0.0006 |
| 452 |
RESPIRATORY FAILURE |
41 |
0.0006 |
| 453 |
RENAL FAILURE |
74 |
0.0006 |
| 454 |
ANAL INCONTINENCE |
5 |
0.0006 |
| 455 |
ATRIAL FIBRILLATION |
54 |
0.0006 |
| 456 |
MYELODYSPLASTIC SYNDROME |
8 |
0.0006 |
| 457 |
DERMATITIS BULLOUS |
4 |
0.0006 |
| 458 |
SKIN LACERATION |
6 |
0.0006 |
| 459 |
SEPTIC SHOCK |
24 |
0.0006 |
| 460 |
OPTIC NEURITIS |
5 |
0.0005 |
| 461 |
MATERNAL EXPOSURE DURING PREGNANCY |
49 |
0.0005 |
| 462 |
HYPERGLYCAEMIA |
20 |
0.0005 |
| 463 |
GASTROENTERITIS |
8 |
0.0005 |
| 464 |
SKIN LESION |
15 |
0.0005 |
| 465 |
GENITAL HAEMORRHAGE |
7 |
0.0005 |
| 466 |
RESPIRATORY DISTRESS |
15 |
0.0005 |
| 467 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0005 |
| 468 |
MEDICAL DEVICE COMPLICATION |
4 |
0.0005 |
| 469 |
ARTHROPOD BITE |
4 |
0.0005 |
| 470 |
RASH MACULO-PAPULAR |
12 |
0.0005 |
| 471 |
FEELING DRUNK |
4 |
0.0005 |
| 472 |
HEPATIC STEATOSIS |
10 |
0.0005 |
| 473 |
IMMUNODEFICIENCY |
8 |
0.0005 |
| 474 |
PULMONARY CONGESTION |
7 |
0.0005 |
| 475 |
STOMATITIS |
32 |
0.0005 |
| 476 |
SPUTUM DISCOLOURED |
5 |
0.0005 |
| 477 |
DYSPHAGIA |
50 |
0.0005 |
| 478 |
SCAB |
6 |
0.0005 |
| 479 |
PRURITUS |
201 |
0.0005 |
| 480 |
SEROTONIN SYNDROME |
10 |
0.0005 |
| 481 |
CHILLS |
61 |
0.0005 |
| 482 |
SEIZURE |
60 |
0.0005 |
| 483 |
DELIRIUM |
18 |
0.0005 |
| 484 |
MUSCULOSKELETAL CHEST PAIN |
8 |
0.0005 |
| 485 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
4 |
0.0005 |
| 486 |
TACHYPNOEA |
7 |
0.0005 |
| 487 |
ACCIDENTAL EXPOSURE TO PRODUCT |
53 |
0.0005 |
| 488 |
IMPAIRED GASTRIC EMPTYING |
7 |
0.0005 |
| 489 |
FEBRILE NEUTROPENIA |
34 |
0.0005 |
| 490 |
SPLENOMEGALY |
6 |
0.0005 |
| 491 |
INFLAMMATORY BOWEL DISEASE |
5 |
0.0005 |
| 492 |
GASTROINTESTINAL INFLAMMATION |
4 |
0.0005 |
| 493 |
ELECTROCARDIOGRAM ABNORMAL |
4 |
0.0005 |
| 494 |
HYPOPHAGIA |
13 |
0.0005 |
| 495 |
ASPARTATE AMINOTRANSFERASE INCREASED |
27 |
0.0005 |
| 496 |
HOSPICE CARE |
5 |
0.0005 |
| 497 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
8 |
0.0005 |
| 498 |
CLOSTRIDIUM DIFFICILE INFECTION |
11 |
0.0005 |
| 499 |
HALLUCINATION, AUDITORY |
8 |
0.0005 |
| 500 |
HAEMOPTYSIS |
14 |
0.0005 |
| 501 |
MUSCLE RIGIDITY |
6 |
0.0005 |
| 502 |
WOUND |
14 |
0.0005 |
| 503 |
SKIN DISCOLOURATION |
23 |
0.0005 |
| 504 |
DISSEMINATED INTRAVASCULAR COAGULATION |
7 |
0.0005 |
| 505 |
SEDATION |
13 |
0.0005 |
| 506 |
DRUG EFFECT INCOMPLETE |
18 |
0.0005 |
| 507 |
URTICARIA |
83 |
0.0005 |
| 508 |
MYASTHENIA GRAVIS |
4 |
0.0005 |
| 509 |
CONSTIPATION |
108 |
0.0005 |
| 510 |
PULMONARY OEDEMA |
22 |
0.0005 |
| 511 |
ASPHYXIA |
4 |
0.0005 |
| 512 |
PANCREATITIS ACUTE |
11 |
0.0005 |
| 513 |
PARALYSIS |
7 |
0.0005 |
| 514 |
CONFUSIONAL STATE |
79 |
0.0005 |
| 515 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
99 |
0.0005 |
| 516 |
METASTASES TO BONE |
8 |
0.0005 |
| 517 |
PHARYNGITIS |
6 |
0.0005 |
| 518 |
BLOOD BILIRUBIN INCREASED |
13 |
0.0005 |
| 519 |
HEMIPLEGIA |
4 |
0.0005 |
| 520 |
THROAT TIGHTNESS |
13 |
0.0005 |
| 521 |
LYMPHADENOPATHY |
17 |
0.0005 |
| 522 |
TENDERNESS |
5 |
0.0005 |
| 523 |
HAEMORRHAGE |
50 |
0.0005 |
| 524 |
ANAEMIA |
91 |
0.0005 |
| 525 |
CEREBRAL HAEMORRHAGE |
17 |
0.0005 |
| 526 |
ANGIOEDEMA |
21 |
0.0005 |
| 527 |
INFUSION SITE ERYTHEMA |
4 |
0.0005 |
| 528 |
PRODUCT COMPLAINT |
12 |
0.0005 |
| 529 |
INCONTINENCE |
5 |
0.0005 |
| 530 |
CONVULSION |
27 |
0.0005 |
| 531 |
RENAL INJURY |
14 |
0.0005 |
| 532 |
INADEQUATE ANALGESIA |
4 |
0.0005 |
| 533 |
PULMONARY MASS |
7 |
0.0005 |
| 534 |
CIRCULATORY COLLAPSE |
8 |
0.0005 |
| 535 |
ROTATOR CUFF SYNDROME |
6 |
0.0005 |
| 536 |
FEELING COLD |
13 |
0.0005 |
| 537 |
BLOOD POTASSIUM DECREASED |
14 |
0.0005 |
| 538 |
DEHYDRATION |
62 |
0.0005 |
| 539 |
PARANOIA |
8 |
0.0005 |
| 540 |
PHARYNGITIS STREPTOCOCCAL |
5 |
0.0005 |
| 541 |
OSTEOPOROSIS |
19 |
0.0005 |
| 542 |
TACHYCARDIA |
41 |
0.0005 |
| 543 |
MUCOSAL INFLAMMATION |
12 |
0.0005 |
| 544 |
APPLICATION SITE ERYTHEMA |
12 |
0.0005 |
| 545 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
25 |
0.0005 |
| 546 |
PRODUCT COMMUNICATION ISSUE |
4 |
0.0005 |
| 547 |
DENTAL CARIES |
5 |
0.0005 |
| 548 |
EAR INFECTION |
12 |
0.0005 |
| 549 |
URINARY RETENTION |
15 |
0.0004 |
| 550 |
OBSTRUCTIVE AIRWAYS DISORDER |
5 |
0.0004 |
| 551 |
ABORTION SPONTANEOUS |
18 |
0.0004 |
| 552 |
CYTOKINE RELEASE SYNDROME |
9 |
0.0004 |
| 553 |
ERYTHEMA |
92 |
0.0004 |
| 554 |
GLOSSODYNIA |
10 |
0.0004 |
| 555 |
ORAL PAIN |
10 |
0.0004 |
| 556 |
HAEMOLYTIC ANAEMIA |
4 |
0.0004 |
| 557 |
HAEMARTHROSIS |
4 |
0.0004 |
| 558 |
MYOSITIS |
4 |
0.0004 |
| 559 |
INTESTINAL PERFORATION |
5 |
0.0004 |
| 560 |
OEDEMA PERIPHERAL |
54 |
0.0004 |
| 561 |
EYE INFECTION |
5 |
0.0004 |
| 562 |
PAIN |
271 |
0.0004 |
| 563 |
INJURY |
31 |
0.0004 |
| 564 |
PALLOR |
12 |
0.0004 |
| 565 |
PNEUMONITIS |
12 |
0.0004 |
| 566 |
SCIATICA |
7 |
0.0004 |
| 567 |
SPEECH DISORDER |
23 |
0.0004 |
| 568 |
EXOSTOSIS |
4 |
0.0004 |
| 569 |
MYOCARDITIS |
5 |
0.0004 |
| 570 |
INTENTIONAL PRODUCT MISUSE |
38 |
0.0004 |
| 571 |
APHASIA |
13 |
0.0004 |
| 572 |
EYE SWELLING |
16 |
0.0004 |
| 573 |
COGNITIVE DISORDER |
20 |
0.0004 |
| 574 |
DRUG RESISTANCE |
11 |
0.0004 |
| 575 |
TUBULOINTERSTITIAL NEPHRITIS |
8 |
0.0004 |
| 576 |
LACERATION |
4 |
0.0004 |
| 577 |
RASH GENERALISED |
11 |
0.0004 |
| 578 |
OEDEMA |
23 |
0.0004 |
| 579 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
12 |
0.0004 |
| 580 |
FRACTURE |
8 |
0.0004 |
| 581 |
SINUS TACHYCARDIA |
6 |
0.0004 |
| 582 |
PLATELET COUNT DECREASED |
45 |
0.0004 |
| 583 |
RASH |
184 |
0.0004 |
| 584 |
IMPAIRED WORK ABILITY |
9 |
0.0004 |
| 585 |
FOETAL EXPOSURE DURING PREGNANCY |
34 |
0.0004 |
| 586 |
ELECTROCARDIOGRAM QT PROLONGED |
15 |
0.0004 |
| 587 |
DRUG PRESCRIBING ERROR |
8 |
0.0004 |
| 588 |
SWOLLEN TONGUE |
13 |
0.0004 |
| 589 |
PARAESTHESIA ORAL |
6 |
0.0004 |
| 590 |
EPISTAXIS |
31 |
0.0004 |
| 591 |
NOCTURIA |
5 |
0.0004 |
| 592 |
CARDIAC FAILURE CONGESTIVE |
33 |
0.0004 |
| 593 |
AUTOIMMUNE DISORDER |
4 |
0.0004 |
| 594 |
OXYGEN SATURATION DECREASED |
23 |
0.0004 |
| 595 |
JAUNDICE |
11 |
0.0004 |
| 596 |
BACK PAIN |
94 |
0.0004 |
| 597 |
GENERALISED OEDEMA |
5 |
0.0004 |
| 598 |
PRODUCT USE IN UNAPPROVED INDICATION |
100 |
0.0004 |
| 599 |
INABILITY TO AFFORD MEDICATION |
4 |
0.0004 |
| 600 |
HERPES ZOSTER |
23 |
0.0004 |
| 601 |
HEPATIC ENZYME INCREASED |
27 |
0.0004 |
| 602 |
PYREXIA |
137 |
0.0004 |
| 603 |
DIABETES MELLITUS INADEQUATE CONTROL |
7 |
0.0004 |
| 604 |
DRUG ERUPTION |
7 |
0.0004 |
| 605 |
DEVICE FAILURE |
6 |
0.0004 |
| 606 |
DRUG LEVEL DECREASED |
4 |
0.0004 |
| 607 |
ABDOMINAL DISTENSION |
41 |
0.0004 |
| 608 |
NEUTROPHIL COUNT DECREASED |
16 |
0.0004 |
| 609 |
MOTOR DYSFUNCTION |
4 |
0.0004 |
| 610 |
HIP ARTHROPLASTY |
6 |
0.0004 |
| 611 |
SHOCK |
9 |
0.0004 |
| 612 |
DRUG EFFECT DECREASED |
21 |
0.0004 |
| 613 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
4 |
0.0004 |
| 614 |
HELICOBACTER INFECTION |
4 |
0.0004 |
| 615 |
GAIT INABILITY |
13 |
0.0004 |
| 616 |
OSTEOMYELITIS |
7 |
0.0004 |
| 617 |
ACCIDENTAL OVERDOSE |
14 |
0.0004 |
| 618 |
PRODUCT ODOUR ABNORMAL |
4 |
0.0004 |
| 619 |
PNEUMOTHORAX |
6 |
0.0004 |
| 620 |
INSOMNIA |
100 |
0.0004 |
| 621 |
IRRITABLE BOWEL SYNDROME |
8 |
0.0004 |
| 622 |
QUALITY OF LIFE DECREASED |
5 |
0.0004 |
| 623 |
GASTROOESOPHAGEAL REFLUX DISEASE |
30 |
0.0004 |
| 624 |
INTERSTITIAL LUNG DISEASE |
18 |
0.0004 |
| 625 |
DECREASED ACTIVITY |
4 |
0.0004 |
| 626 |
PRESYNCOPE |
9 |
0.0004 |
| 627 |
HAEMOGLOBIN DECREASED |
38 |
0.0004 |
| 628 |
PRURITUS GENERALISED |
8 |
0.0004 |
| 629 |
SYNCOPE |
37 |
0.0004 |
| 630 |
DRY MOUTH |
30 |
0.0004 |
| 631 |
ALTERED STATE OF CONSCIOUSNESS |
8 |
0.0004 |
| 632 |
FOOT FRACTURE |
7 |
0.0004 |
| 633 |
ADVERSE DRUG REACTION |
33 |
0.0004 |
| 634 |
DRUG TOXICITY |
5 |
0.0004 |
| 635 |
INTERVERTEBRAL DISC PROTRUSION |
8 |
0.0004 |
| 636 |
LETHARGY |
21 |
0.0004 |
| 637 |
ABDOMINAL PAIN UPPER |
75 |
0.0004 |
| 638 |
PHOTOSENSITIVITY REACTION |
6 |
0.0004 |
| 639 |
DIVERTICULITIS |
10 |
0.0004 |
| 640 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
65 |
0.0004 |
| 641 |
MEDICATION ERROR |
20 |
0.0004 |
| 642 |
ORAL HERPES |
7 |
0.0004 |
| 643 |
COORDINATION ABNORMAL |
5 |
0.0004 |
| 644 |
DIARRHOEA |
230 |
0.0004 |
| 645 |
FACE OEDEMA |
6 |
0.0004 |
| 646 |
DIALYSIS |
5 |
0.0004 |
| 647 |
HEPATITIS |
9 |
0.0004 |
| 648 |
BONE DENSITY DECREASED |
11 |
0.0004 |
| 649 |
ERECTILE DYSFUNCTION |
9 |
0.0004 |
| 650 |
PREGNANCY |
7 |
0.0003 |
| 651 |
ANGINA PECTORIS |
10 |
0.0003 |
| 652 |
LUNG DISORDER |
17 |
0.0003 |
| 653 |
UPPER RESPIRATORY TRACT INFECTION |
16 |
0.0003 |
| 654 |
METASTASES TO LUNG |
4 |
0.0003 |
| 655 |
ANOSMIA |
5 |
0.0003 |
| 656 |
HYPERTHYROIDISM |
5 |
0.0003 |
| 657 |
PULMONARY ARTERIAL HYPERTENSION |
5 |
0.0003 |
| 658 |
GAIT DISTURBANCE |
66 |
0.0003 |
| 659 |
HYPERTENSION |
73 |
0.0003 |
| 660 |
DYSKINESIA |
14 |
0.0003 |
| 661 |
ELECTROLYTE IMBALANCE |
4 |
0.0003 |
| 662 |
POST PROCEDURAL HAEMORRHAGE |
4 |
0.0003 |
| 663 |
JOINT STIFFNESS |
9 |
0.0003 |
| 664 |
NIGHT SWEATS |
11 |
0.0003 |
| 665 |
RIB FRACTURE |
7 |
0.0003 |
| 666 |
BLOOD TRIGLYCERIDES INCREASED |
6 |
0.0003 |
| 667 |
LYMPHOCYTE COUNT DECREASED |
6 |
0.0003 |
| 668 |
BRADYCARDIA |
18 |
0.0003 |
| 669 |
WHITE BLOOD CELL COUNT INCREASED |
13 |
0.0003 |
| 670 |
DEEP VEIN THROMBOSIS |
22 |
0.0003 |
| 671 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
24 |
0.0003 |
| 672 |
WHEEZING |
20 |
0.0003 |
| 673 |
BLOOD IRON DECREASED |
4 |
0.0003 |
| 674 |
PULMONARY EMBOLISM |
32 |
0.0003 |
| 675 |
CARDIAC FAILURE |
27 |
0.0003 |
| 676 |
GALLBLADDER DISORDER |
6 |
0.0003 |
| 677 |
CHOLECYSTITIS |
4 |
0.0003 |
| 678 |
THERAPEUTIC RESPONSE UNEXPECTED |
15 |
0.0003 |
| 679 |
RENAL IMPAIRMENT |
28 |
0.0003 |
| 680 |
ANXIETY |
94 |
0.0003 |
| 681 |
LOWER RESPIRATORY TRACT INFECTION |
15 |
0.0003 |
| 682 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
13 |
0.0003 |
| 683 |
RETCHING |
7 |
0.0003 |
| 684 |
ABNORMAL BEHAVIOUR |
13 |
0.0003 |
| 685 |
DISORIENTATION |
13 |
0.0003 |
| 686 |
DIABETES MELLITUS |
25 |
0.0003 |
| 687 |
DYSPNOEA |
185 |
0.0003 |
| 688 |
TYPE 2 DIABETES MELLITUS |
11 |
0.0003 |
| 689 |
ANAPHYLACTIC REACTION |
18 |
0.0003 |
| 690 |
SKIN CANCER |
7 |
0.0003 |
| 691 |
ANKLE FRACTURE |
5 |
0.0003 |
| 692 |
DECREASED APPETITE |
75 |
0.0003 |
| 693 |
RENAL DISORDER |
15 |
0.0003 |
| 694 |
ILEUS |
4 |
0.0003 |
| 695 |
HEPATIC FUNCTION ABNORMAL |
12 |
0.0003 |
| 696 |
MIDDLE INSOMNIA |
6 |
0.0003 |
| 697 |
PNEUMONIA |
104 |
0.0003 |
| 698 |
TREMOR |
53 |
0.0003 |
| 699 |
CATARACT |
19 |
0.0003 |
| 700 |
HYPOTENSION |
64 |
0.0003 |
| 701 |
INFECTION |
46 |
0.0003 |
| 702 |
MUSCLE ATROPHY |
4 |
0.0003 |
| 703 |
PROTEINURIA |
6 |
0.0003 |
| 704 |
FEELING JITTERY |
6 |
0.0003 |
| 705 |
RED BLOOD CELL COUNT DECREASED |
9 |
0.0003 |
| 706 |
ULCER |
5 |
0.0003 |
| 707 |
PRODUCT USE ISSUE |
59 |
0.0003 |
| 708 |
ABSCESS |
5 |
0.0003 |
| 709 |
OROPHARYNGEAL PAIN |
29 |
0.0003 |
| 710 |
AGITATION |
23 |
0.0003 |
| 711 |
HEART RATE INCREASED |
31 |
0.0003 |
| 712 |
PULMONARY FIBROSIS |
6 |
0.0003 |
| 713 |
CHEST DISCOMFORT |
32 |
0.0003 |
| 714 |
POST PROCEDURAL COMPLICATION |
6 |
0.0003 |
| 715 |
GLAUCOMA |
6 |
0.0003 |
| 716 |
ANOREXIA |
4 |
0.0003 |
| 717 |
PRESCRIBED OVERDOSE |
6 |
0.0003 |
| 718 |
UNRESPONSIVE TO STIMULI |
8 |
0.0003 |
| 719 |
DIZZINESS |
154 |
0.0003 |
| 720 |
ASTHENIA |
116 |
0.0003 |
| 721 |
DEPRESSION |
70 |
0.0003 |
| 722 |
CHOKING |
6 |
0.0003 |
| 723 |
DEAFNESS |
8 |
0.0003 |
| 724 |
ECZEMA |
16 |
0.0003 |
| 725 |
EMOTIONAL DISTRESS |
37 |
0.0003 |
| 726 |
MUSCULOSKELETAL PAIN |
16 |
0.0003 |
| 727 |
NEPHROLITHIASIS |
14 |
0.0003 |
| 728 |
LABORATORY TEST ABNORMAL |
9 |
0.0003 |
| 729 |
CHOLELITHIASIS |
10 |
0.0003 |
| 730 |
WEIGHT DECREASED |
85 |
0.0003 |
| 731 |
ABDOMINAL DISCOMFORT |
51 |
0.0003 |
| 732 |
GASTRITIS |
8 |
0.0003 |
| 733 |
SINUS DISORDER |
6 |
0.0003 |
| 734 |
CARDIAC ARREST |
25 |
0.0003 |
| 735 |
DYSMENORRHOEA |
4 |
0.0003 |
| 736 |
UPPER LIMB FRACTURE |
6 |
0.0003 |
| 737 |
RESPIRATORY DISORDER |
9 |
0.0003 |
| 738 |
DRY EYE |
15 |
0.0003 |
| 739 |
LEUKOPENIA |
15 |
0.0003 |
| 740 |
EYE HAEMORRHAGE |
4 |
0.0003 |
| 741 |
PALPITATIONS |
35 |
0.0003 |
| 742 |
CORONARY ARTERY DISEASE |
9 |
0.0003 |
| 743 |
NAUSEA |
235 |
0.0003 |
| 744 |
INJURY ASSOCIATED WITH DEVICE |
6 |
0.0003 |
| 745 |
DRUG ADMINISTRATION ERROR |
9 |
0.0003 |
| 746 |
MOBILITY DECREASED |
21 |
0.0003 |
| 747 |
EMOTIONAL DISORDER |
9 |
0.0003 |
| 748 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
14 |
0.0003 |
| 749 |
GASTRIC DISORDER |
10 |
0.0003 |
| 750 |
APPLICATION SITE RASH |
4 |
0.0003 |
| 751 |
NIGHTMARE |
10 |
0.0003 |
| 752 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
15 |
0.0003 |
| 753 |
OFF LABEL USE |
251 |
0.0003 |
| 754 |
LOCAL SWELLING |
5 |
0.0003 |
| 755 |
APHONIA |
4 |
0.0003 |
| 756 |
CEREBRAL INFARCTION |
7 |
0.0003 |
| 757 |
VOMITING |
134 |
0.0003 |
| 758 |
BLOOD TEST ABNORMAL |
4 |
0.0003 |
| 759 |
METASTASES TO LIVER |
5 |
0.0003 |
| 760 |
FEELING ABNORMAL |
68 |
0.0003 |
| 761 |
COLD SWEAT |
5 |
0.0003 |
| 762 |
MUSCLE SPASMS |
52 |
0.0003 |
| 763 |
LYMPHOPENIA |
4 |
0.0003 |
| 764 |
HEAD DISCOMFORT |
5 |
0.0003 |
| 765 |
BRONCHOSPASM |
4 |
0.0003 |
| 766 |
HYPERSOMNIA |
8 |
0.0003 |
| 767 |
GOUT |
5 |
0.0003 |
| 768 |
ACCIDENTAL UNDERDOSE |
4 |
0.0003 |
| 769 |
PRODUCT SUBSTITUTION ISSUE |
16 |
0.0003 |
| 770 |
DEVICE DISLOCATION |
12 |
0.0003 |
| 771 |
MENTAL DISORDER |
12 |
0.0003 |
| 772 |
CARDIOVASCULAR DISORDER |
7 |
0.0003 |
| 773 |
TREATMENT NONCOMPLIANCE |
15 |
0.0003 |
| 774 |
DYSSTASIA |
8 |
0.0003 |
| 775 |
RESTLESSNESS |
10 |
0.0003 |
| 776 |
PRODUCTIVE COUGH |
13 |
0.0003 |
| 777 |
ANAPHYLACTIC SHOCK |
7 |
0.0003 |
| 778 |
VIRAL INFECTION |
9 |
0.0003 |
| 779 |
RESPIRATORY TRACT INFECTION |
7 |
0.0003 |
| 780 |
HYPOGLYCAEMIA |
13 |
0.0003 |
| 781 |
RASH PAPULAR |
6 |
0.0003 |
| 782 |
WHITE BLOOD CELL COUNT DECREASED |
29 |
0.0003 |
| 783 |
TRANSIENT ISCHAEMIC ATTACK |
9 |
0.0003 |
| 784 |
PERIPHERAL SWELLING |
41 |
0.0003 |
| 785 |
HEPATIC CIRRHOSIS |
5 |
0.0003 |
| 786 |
DYSARTHRIA |
10 |
0.0003 |
| 787 |
SKIN BURNING SENSATION |
19 |
0.0003 |
| 788 |
MYALGIA |
45 |
0.0003 |
| 789 |
FLATULENCE |
15 |
0.0003 |
| 790 |
ILL-DEFINED DISORDER |
16 |
0.0003 |
| 791 |
CARDIO-RESPIRATORY ARREST |
11 |
0.0003 |
| 792 |
INCREASED APPETITE |
5 |
0.0003 |
| 793 |
BLOOD PRESSURE INCREASED |
40 |
0.0003 |
| 794 |
INSURANCE ISSUE |
4 |
0.0003 |
| 795 |
MENSTRUATION IRREGULAR |
7 |
0.0003 |
| 796 |
THROMBOSIS |
21 |
0.0003 |
| 797 |
FEAR |
7 |
0.0003 |
| 798 |
RASH MACULAR |
9 |
0.0003 |
| 799 |
NEUTROPENIA |
35 |
0.0003 |
| 800 |
EAR PAIN |
5 |
0.0003 |
| 801 |
HYPERKALAEMIA |
9 |
0.0003 |
| 802 |
KIDNEY INFECTION |
5 |
0.0003 |
| 803 |
SOMNOLENCE |
51 |
0.0003 |
| 804 |
OCULAR HYPERAEMIA |
12 |
0.0003 |
| 805 |
HEAD INJURY |
8 |
0.0003 |
| 806 |
COMA |
12 |
0.0003 |
| 807 |
PRODUCT QUALITY ISSUE |
34 |
0.0003 |
| 808 |
DIABETIC KETOACIDOSIS |
6 |
0.0002 |
| 809 |
LOSS OF CONSCIOUSNESS |
32 |
0.0002 |
| 810 |
HIP FRACTURE |
8 |
0.0002 |
| 811 |
LIVER DISORDER |
11 |
0.0002 |
| 812 |
PARAESTHESIA |
39 |
0.0002 |
| 813 |
PAIN IN EXTREMITY |
73 |
0.0002 |
| 814 |
DRY SKIN |
33 |
0.0002 |
| 815 |
TASTE DISORDER |
5 |
0.0002 |
| 816 |
FALL |
82 |
0.0002 |
| 817 |
VERTIGO |
15 |
0.0002 |
| 818 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
7 |
0.0002 |
| 819 |
GENERALISED TONIC-CLONIC SEIZURE |
4 |
0.0002 |
| 820 |
ARTHRITIS |
19 |
0.0002 |
| 821 |
BLOOD PRESSURE DECREASED |
16 |
0.0002 |
| 822 |
AGEUSIA |
6 |
0.0002 |
| 823 |
INTENTIONAL PRODUCT USE ISSUE |
21 |
0.0002 |
| 824 |
ROAD TRAFFIC ACCIDENT |
10 |
0.0002 |
| 825 |
DYSPNOEA EXERTIONAL |
9 |
0.0002 |
| 826 |
HALLUCINATION |
18 |
0.0002 |
| 827 |
HOT FLUSH |
18 |
0.0002 |
| 828 |
ASCITES |
7 |
0.0002 |
| 829 |
COLITIS |
9 |
0.0002 |
| 830 |
MALAISE |
104 |
0.0002 |
| 831 |
HALLUCINATION, VISUAL |
5 |
0.0002 |
| 832 |
FLUID RETENTION |
12 |
0.0002 |
| 833 |
SINUSITIS |
24 |
0.0002 |
| 834 |
LIVER FUNCTION TEST INCREASED |
5 |
0.0002 |
| 835 |
HYPERHIDROSIS |
30 |
0.0002 |
| 836 |
IRRITABILITY |
14 |
0.0002 |
| 837 |
MUSCULOSKELETAL DISCOMFORT |
4 |
0.0002 |
| 838 |
DIPLOPIA |
6 |
0.0002 |
| 839 |
FAECES DISCOLOURED |
5 |
0.0002 |
| 840 |
BLOOD GLUCOSE DECREASED |
11 |
0.0002 |
| 841 |
TRANSAMINASES INCREASED |
5 |
0.0002 |
| 842 |
CARDIAC DISORDER |
21 |
0.0002 |
| 843 |
NERVOUS SYSTEM DISORDER |
7 |
0.0002 |
| 844 |
ISCHAEMIC STROKE |
4 |
0.0002 |
| 845 |
HEADACHE |
140 |
0.0002 |
| 846 |
THERAPY NON-RESPONDER |
10 |
0.0002 |
| 847 |
HOSPITALISATION |
34 |
0.0002 |
| 848 |
HEART RATE IRREGULAR |
5 |
0.0002 |
| 849 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
8 |
0.0002 |
| 850 |
C-REACTIVE PROTEIN INCREASED |
8 |
0.0002 |
| 851 |
HYPOTHYROIDISM |
7 |
0.0002 |
| 852 |
MOVEMENT DISORDER |
7 |
0.0002 |
| 853 |
RESPIRATORY ARREST |
6 |
0.0002 |
| 854 |
ARTHRALGIA |
90 |
0.0002 |
| 855 |
PROCEDURAL PAIN |
6 |
0.0002 |
| 856 |
INFLUENZA |
24 |
0.0002 |
| 857 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
5 |
0.0002 |
| 858 |
BACTERIAL INFECTION |
4 |
0.0002 |
| 859 |
EYE DISORDER |
7 |
0.0002 |
| 860 |
CEREBROVASCULAR ACCIDENT |
36 |
0.0002 |
| 861 |
ASTHMA |
24 |
0.0002 |
| 862 |
FEELING HOT |
13 |
0.0002 |
| 863 |
PRODUCT DOSE OMISSION IN ERROR |
6 |
0.0002 |
| 864 |
MEMORY IMPAIRMENT |
29 |
0.0002 |
| 865 |
MIGRAINE |
20 |
0.0002 |
| 866 |
BALANCE DISORDER |
18 |
0.0002 |
| 867 |
HERNIA |
4 |
0.0002 |
| 868 |
MENTAL IMPAIRMENT |
5 |
0.0002 |
| 869 |
NEURALGIA |
5 |
0.0002 |
| 870 |
FATIGUE |
160 |
0.0002 |
| 871 |
PLASMA CELL MYELOMA |
8 |
0.0002 |
| 872 |
LIVER INJURY |
5 |
0.0002 |
| 873 |
DISEASE PROGRESSION |
24 |
0.0002 |
| 874 |
DISABILITY |
4 |
0.0002 |
| 875 |
OSTEONECROSIS OF JAW |
5 |
0.0002 |
| 876 |
BLOOD GLUCOSE INCREASED |
38 |
0.0002 |
| 877 |
EXTRAPYRAMIDAL DISORDER |
5 |
0.0002 |
| 878 |
RHINORRHOEA |
13 |
0.0002 |
| 879 |
AMNESIA |
13 |
0.0002 |
| 880 |
HAEMATOCHEZIA |
11 |
0.0002 |
| 881 |
GENERAL PHYSICAL HEALTH DETERIORATION |
23 |
0.0002 |
| 882 |
LACRIMATION INCREASED |
6 |
0.0002 |
| 883 |
FEEDING DISORDER |
4 |
0.0002 |
| 884 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
7 |
0.0002 |
| 885 |
BODY TEMPERATURE INCREASED |
4 |
0.0002 |
| 886 |
TINNITUS |
9 |
0.0002 |
| 887 |
EYE PAIN |
11 |
0.0002 |
| 888 |
INFLUENZA LIKE ILLNESS |
16 |
0.0002 |
| 889 |
CHEST PAIN |
36 |
0.0002 |
| 890 |
INFLAMMATION |
10 |
0.0002 |
| 891 |
HYPOAESTHESIA |
29 |
0.0002 |
| 892 |
DYSPEPSIA |
19 |
0.0002 |
| 893 |
PANIC ATTACK |
7 |
0.0002 |
| 894 |
RHABDOMYOLYSIS |
8 |
0.0002 |
| 895 |
VISION BLURRED |
26 |
0.0002 |
| 896 |
COUGH |
53 |
0.0002 |
| 897 |
MOOD SWINGS |
6 |
0.0002 |
| 898 |
COVID-19 |
33 |
0.0002 |
| 899 |
EATING DISORDER |
4 |
0.0002 |
| 900 |
JOINT INJURY |
4 |
0.0002 |
| 901 |
NASAL CONGESTION |
11 |
0.0002 |
| 902 |
FREQUENT BOWEL MOVEMENTS |
5 |
0.0002 |
| 903 |
PRODUCT DISPENSING ERROR |
4 |
0.0002 |
| 904 |
ARTHROPATHY |
10 |
0.0002 |
| 905 |
EYE PRURITUS |
6 |
0.0002 |
| 906 |
TARDIVE DYSKINESIA |
5 |
0.0002 |
| 907 |
PRODUCT AVAILABILITY ISSUE |
4 |
0.0002 |
| 908 |
DYSGEUSIA |
13 |
0.0002 |
| 909 |
SUICIDAL IDEATION |
16 |
0.0002 |
| 910 |
EYE IRRITATION |
10 |
0.0002 |
| 911 |
ADVERSE EVENT |
16 |
0.0002 |
| 912 |
NEOPLASM PROGRESSION |
6 |
0.0002 |
| 913 |
BONE PAIN |
10 |
0.0002 |
| 914 |
ACUTE MYOCARDIAL INFARCTION |
5 |
0.0002 |
| 915 |
ARRHYTHMIA |
8 |
0.0002 |
| 916 |
HEPATIC FAILURE |
5 |
0.0002 |
| 917 |
LOCALISED INFECTION |
4 |
0.0002 |
| 918 |
ALOPECIA |
32 |
0.0002 |
| 919 |
HYPOACUSIS |
7 |
0.0002 |
| 920 |
BRONCHITIS |
12 |
0.0002 |
| 921 |
LIMB DISCOMFORT |
5 |
0.0002 |
| 922 |
NECK PAIN |
9 |
0.0002 |
| 923 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
4 |
0.0002 |
| 924 |
INCORRECT DOSE ADMINISTERED |
36 |
0.0002 |
| 925 |
WEIGHT INCREASED |
35 |
0.0002 |
| 926 |
DEVICE ISSUE |
14 |
0.0002 |
| 927 |
LACTIC ACIDOSIS |
5 |
0.0002 |
| 928 |
PHARMACEUTICAL PRODUCT COMPLAINT |
4 |
0.0002 |
| 929 |
DYSPHONIA |
9 |
0.0002 |
| 930 |
NERVOUSNESS |
8 |
0.0002 |
| 931 |
PRODUCT DOSE OMISSION ISSUE |
45 |
0.0002 |
| 932 |
IMPAIRED HEALING |
5 |
0.0002 |
| 933 |
VISUAL ACUITY REDUCED |
5 |
0.0002 |
| 934 |
MUSCULOSKELETAL STIFFNESS |
13 |
0.0001 |
| 935 |
DISTURBANCE IN ATTENTION |
8 |
0.0001 |
| 936 |
LIMB INJURY |
4 |
0.0001 |
| 937 |
DISEASE RECURRENCE |
7 |
0.0001 |
| 938 |
MULTIPLE SCLEROSIS RELAPSE |
10 |
0.0001 |
| 939 |
ILLNESS |
15 |
0.0001 |
| 940 |
DRUG DOSE OMISSION |
24 |
0.0001 |
| 941 |
GASTROINTESTINAL DISORDER |
13 |
0.0001 |
| 942 |
OVERDOSE |
31 |
0.0001 |
| 943 |
NASOPHARYNGITIS |
26 |
0.0001 |
| 944 |
PANCREATIC CARCINOMA |
4 |
0.0001 |
| 945 |
FLUSHING |
14 |
0.0001 |
| 946 |
SURGERY |
8 |
0.0001 |
| 947 |
THERAPY CESSATION |
7 |
0.0001 |
| 948 |
PSYCHOTIC DISORDER |
4 |
0.0001 |
| 949 |
INTESTINAL OBSTRUCTION |
5 |
0.0001 |
| 950 |
THERAPEUTIC RESPONSE DECREASED |
8 |
0.0001 |
| 951 |
NO ADVERSE EVENT |
23 |
0.0001 |
| 952 |
METABOLIC ACIDOSIS |
4 |
0.0001 |
| 953 |
JOINT SWELLING |
15 |
0.0001 |
| 954 |
VISUAL IMPAIRMENT |
15 |
0.0001 |
| 955 |
INFUSION RELATED REACTION |
8 |
0.0001 |
| 956 |
AGGRESSION |
6 |
0.0001 |
| 957 |
NEOPLASM MALIGNANT |
8 |
0.0001 |
| 958 |
ANGER |
4 |
0.0001 |
| 959 |
DEVICE LEAKAGE |
5 |
0.0001 |
| 960 |
DEVICE USE ERROR |
4 |
0.0001 |
| 961 |
PSORIASIS |
15 |
0.0001 |
| 962 |
HEART RATE DECREASED |
4 |
0.0001 |
| 963 |
DRUG INTOLERANCE |
11 |
0.0001 |
| 964 |
DEPRESSED MOOD |
6 |
0.0001 |
| 965 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
5 |
0.0001 |
| 966 |
THROAT IRRITATION |
5 |
0.0001 |
| 967 |
INJECTION SITE MASS |
4 |
0.0001 |
| 968 |
BLOOD CHOLESTEROL INCREASED |
5 |
0.0001 |
| 969 |
DEATH |
90 |
0.0001 |
| 970 |
TOXICITY TO VARIOUS AGENTS |
17 |
0.0001 |
| 971 |
SUICIDE ATTEMPT |
6 |
0.0001 |
| 972 |
EXTRA DOSE ADMINISTERED |
4 |
0.0001 |
| 973 |
PSORIATIC ARTHROPATHY |
4 |
0.0001 |
| 974 |
BLINDNESS |
4 |
0.0001 |
| 975 |
THERAPY INTERRUPTED |
7 |
0.0001 |
| 976 |
DERMATITIS ATOPIC |
5 |
0.0001 |
| 977 |
PANCREATITIS |
5 |
0.0001 |
| 978 |
ACNE |
7 |
0.0001 |
| 979 |
PRODUCT DOSE OMISSION |
6 |
0.0001 |
| 980 |
MALIGNANT NEOPLASM PROGRESSION |
9 |
0.0001 |
| 981 |
DEVICE MALFUNCTION |
6 |
0.0001 |
| 982 |
DRUG DEPENDENCE |
13 |
0.0001 |
| 983 |
RHEUMATOID ARTHRITIS |
9 |
0.0001 |
| 984 |
INJECTION SITE HAEMORRHAGE |
6 |
0.0001 |
| 985 |
TREATMENT FAILURE |
6 |
0.0001 |
| 986 |
COMPLETED SUICIDE |
6 |
0.0001 |
| 987 |
INTENTIONAL OVERDOSE |
4 |
0.0001 |
| 988 |
MYOCARDIAL INFARCTION |
10 |
0.0001 |
| 989 |
INJECTION SITE PAIN |
17 |
0.0001 |
| 990 |
INJECTION SITE ERYTHEMA |
6 |
0.0000 |
| 991 |
DRUG WITHDRAWAL SYNDROME |
4 |
0.0000 |
| 992 |
BREAST CANCER |
4 |
0.0000 |